Your browser doesn't support javascript.
loading
Immunomodulatory effects of carbon ion radiotherapy in patients with localized prostate cancer.
Hu, Wei; Pei, Yulei; Ning, Renli; Li, Ping; Zhang, Zhenshan; Hong, Zhengshan; Bao, Cihang; Guo, Xiaomao; Sun, Yun; Zhang, Qing.
Affiliation
  • Hu W; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.
  • Pei Y; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.
  • Ning R; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.
  • Li P; Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.
  • Zhang Z; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.
  • Hong Z; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.
  • Bao C; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.
  • Guo X; Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, 201321, China.
  • Sun Y; Department of Research and Development, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai, 201321, China.
  • Zhang Q; Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai, China.
J Cancer Res Clin Oncol ; 149(8): 4533-4545, 2023 Jul.
Article in En | MEDLINE | ID: mdl-36138265
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Heavy Ion Radiotherapy Limits: Humans / Male Language: En Journal: J Cancer Res Clin Oncol Year: 2023 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Heavy Ion Radiotherapy Limits: Humans / Male Language: En Journal: J Cancer Res Clin Oncol Year: 2023 Document type: Article Affiliation country: China